| Application no. and date | 19858883.2 (espacenet) (Federated) (European Patent Register), 20190909 | | Patent/reg. no. and date | DK/EP 3849534, 20250305 | | Publication date | 20210721 | | Priority no. and date | US 201862729169 P, 20180910 | | EP pub. no. and date |
EP 3849534 20210721 | | Effective date | | | Applicant/owner | Mirati Therapeutics, Inc., Route 206 and Province Line Road
Princeton, New Jersey 08543, US | | Applicant ref. no. | PU283123DKQ | | Inventor | ENGSTROM, Lars, Daniel, 7974 Amargosa Dr.
Carlsbad, CA 92009, US,
ARANDA, Ruth, Wei, 10797 San Diego Mission Rd. Unit 311
San Diego, CA 92108, US,
OLSON, Peter, 4763 Robbins St.
San Diego, CA 92122, US,
CHRISTENSEN, James, Gail, 4276 Kenwood ct.
San Diego, CA 92130, US | | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/5025 (2006.01) , A61K 31/506 (2006.01) , A61K 31/517 (2006.01) , A61K 31/519 (2006.01) , A61K 31/5377 (2006.01) , A61K 31/541 (2006.01) , A61K 31/553 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) | | Title | KOMBINATION AF DASATINIB OG ADAGRASIB TIL ANVENDELSE I BEHANDLING AF IKKE-SMÅCELLET LUNGECANCER | | Int. application no. | US2019050224 | | Int. publication no. | WO2020055755 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
